Irish Medicines Board Name Change

Posted on:17 Jun 2014

Cystic Fibrosis Research Award

t will become the ‘Health Products Regulatory Authority’ (HPRA).

This is to reflect the expansion of their remit to include other health products as well as health related functions over the past 18 years.

They state that ‘our new name now more clearly reflects the wider scope of our work, functions and responsibilities across the health products sector’.

Please note this may require a change in study documents/ SOPs etc. where IMB is mentioned.

The email addresses will change from to on 1st July, but the old IMB email addresses will work for a transitional period (unspecified).

See IMB website for more details.

Coronavirus (COVID-19)

In light of the Covid-19 situation, in advance of attending for a scheduled patient visit, please confirm the visit with your research nurse.